More Info about MTEN.
                                           FY END JUN                                ISSUE DATA (12/31/99)      PER SHARE DATA               RATIOS               Price    $     0.03      EPS (TTM)  $    -0.03   P/E (TTM)          NM           52W High $     0.23      Div. Rate  $     0.00   Yield            0.00 %         52W Low  $     0.02      Book Value $    -0.01   Price/Book         NM           Shrs Out      27.41 Mil  Cash       $     0.00   ROE (TTM)          NM %         Float         19.20 Mil  Rev (TTM)  $     0.18   ROA (TTM)      -20.21 %         Mon. Vol       1.56 Mil                          Curr. Ratio      0.50           Beta          -3.22                              LT Dbt/Eqty      0.34                BRIEF:  Medical Technology & Innovations is engaged in the                       design, manufacture and distribution of medical screening                        devices for medical professionals primarily involved in                          vision screening.  MTEN also distributes digital and glass                       thermometers and other devices.  For the 9 months ended                          3/31/99, revenues rose 14% to $4.3M.  Net loss fell 67% to                       $295K.  Revenues reflect increased demand for the MTI                            PhotoScreener.  Loss also benefitted from higher margins.                                                                                                                                                                                     Copyright (c) 2000, Market Guide Inc., All rights reserved        (more)        
  Medical Tech. & Innovat.  QUARTERLY SUMMARY                 Page 2 of 10                HISTORICAL QUARTERLY RESULTS(Thousands of U.S. Dollars)                   REVENUE                        1996        1997        1998        1999          1st Qtr    SEP                  152         832         985       1,352          2nd Qtr    DEC                  119       1,015       1,425       1,820          3rd Qtr    MAR                  191         931       1,315       1,091          4th Qtr    JUN                  234         855         816                      EPS                    (U.S. Dollars per share)                                  1st Qtr    SEP               -0.016      -0.055      -0.032      -0.003          2nd Qtr    DEC               -0.030      -0.071      -0.011       0.006          3rd Qtr    MAR               -0.030      -0.065      -0.010      -0.015          4th Qtr    JUN               -0.079      -0.058      -0.014                                                                                                            During 9/97, all Series A Preferred stock converted into                         8,216,772 Common.                                                                                                                                                      DIVIDENDS                          EMPLOYEES                                Last Dividend Decl.    $    NA     # Employees                  38               Last Div Ex-Date            NA     Sales/Employee (TTM)    133,658               Last Div Pay Date           NA     Net. Income/Empl.(TTM)       NM                                                                                           Copyright (c) 2000, Market Guide Inc., All rights reserved        (more)        
  Medical Tech. & Innovat.       EQUITY, OFFICERS & ADDRESS   Page 5 of 10         Common Stock no Par, 3/99, 700M auth., 28,783,541 issd.,                         less 1,373,531 shares in Treas. @ $310K.  Insiders own 30%.                      10/95, 10,263,733 shs. issd. in rev. acq. of Medical Tech.                       Inc.  (As of 6/98)  LTD:  $377K @ 12%, $1.6M @ 8% - 11.25%,                      $127K @ 0% - 10%, $60K @ Prime + 7%.  Conv. Pref. Series B,                      $100 Par, 267 issd.;  Pref. Stock $1000 par, 22.5 issd.                                                                                                           OFFICERS:  Robert D. Brennan, Pres./COO, Jeremy P. Feakings,                     Chmn./CEO, Dennis A. Surovcik, Sr. VP/CFO/Secy., John                            Stefanick, Exec. VP  TRANSFER AGENT:  Interwest Transfer                         Company.  Company incorporated 1989 in FL.  Direct inquiries                     to:  Dennis A. Surovczik, Sr. VP/CFO/Secy.                                          ADDRESS & PHONE NUMBERS                                                       Medical Tech. & Innovat.                                                         615 Centerville Road                                                             Lancaster, PA  17601                                                             PHONE: (717) 892-6770                                                              FAX: (___) ___-____                                                                                                                                                                                                                              Copyright (c) 2000, Market Guide Inc., All rights reserved        (more)         |